Earnings
NLY
21.37
+1.14%
0.24
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2025
7.13B
7.13B
--
4.88B
2.24B
199.63M
199.63M
--
--
--
--
0.00
2.04B
--
--
--
2.04B
-6.87M
2.05B
24.43M
--
--
2.03B
--
2.03B
-157.93M
1.87B
1.87B
--
1.87B
641.04M
2.92
2.92
2.80
2.95
FY 2024
5.84B
5.84B
--
4.64B
1.20B
171.36M
171.36M
--
--
--
0.00
0.00
1.03B
--
--
--
1.03B
15.26M
1.01B
9.86M
--
--
1.00B
--
1.00B
-154.55M
847.36M
847.36M
--
847.36M
522.75M
1.62
1.62
2.60
1.67
FY 2023
2.44B
2.44B
--
3.88B
-1.44B
162.33M
162.55M
--
--
--
0.00
-219.00K
-1.60B
--
--
--
-1.60B
39.43M
-1.64B
4.71M
--
--
-1.64B
--
-1.64B
-141.68M
-1.78B
-1.78B
--
-1.78B
494.54M
-3.61
-3.61
2.60
-3.53
FY 2022
3.29B
3.29B
--
1.33B
1.95B
182.33M
162.73M
--
--
--
40.26M
-20.66M
1.77B
--
--
--
1.77B
45.57M
1.73B
1.09M
--
--
1.73B
--
1.73B
-110.62M
1.61B
1.61B
--
1.61B
411.62M
3.92
3.92
4.40
4.15
FY 2021
2.97B
2.97B
--
249.24M
2.72B
323.81M
186.01M
--
--
--
282.86M
-145.07M
2.40B
--
--
--
2.40B
4.67M
2.40B
6.38M
--
--
2.39B
--
2.39B
-107.53M
2.28B
2.28B
--
2.28B
357.14M
6.39
6.39
3.52
7.20

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.